No change in ACE2 levels was detected in CHF compensated (0.39 ± 0.05 ng/mL) and decompensated (0.45 ± 0.11 ng/mL) subgroups as compared with their sham controls (0.39 ± 0.09 ng/mL). The gene discussed is ACE2; the disease is congestive heart failure.